
Loading, please wait...

Loading, please wait...

Recent pharmacological research explores the isoprenoid antimetabolic activity against Pseudomonas aeruginosa, a persistent clinical pathogen. In this systematic study, researchers evaluated canonical C5/C10 terpenes alongside novel non-canonical C6, C7, and C11 isoprenoids. The results indicate that carbon number alone does not determine antimicrobial efficacy. Instead, short-chain C6-C7 compounds demonstrated more potent suppression profiles than larger C10-C11 molecules. Additionally, methyl-substitution patterns significantly influenced the metabolic recovery of the bacteria.
Positioning of the methyl group serves as a primary driver of the antimetabolic phenotype. For example, specific dimethyl-isoprenol isomers at the C7 position determined the threshold for bacterial suppression. Furthermore, oxygenation status impacts the duration of metabolic inhibition. Specifically, the oxygenated compound geraniol suppressed metabolic activity more effectively than bicyclic monoterpenes like β-pinene. Consequently, these findings prioritize selected C6-C7 scaffolds for further development. Furthermore, these structural insights facilitate the design of more targeted anti-infective agents against resistant strains.
The study also revealed that methylation modulates activity in a scaffold-dependent manner. Rather than uniformly enhancing efficacy, methylation changes based on the molecular skeleton and specific position. This nuanced understanding allows for better discrimination between compounds. Therefore, tailoring the molecular skeleton could potentially overcome common resistance mechanisms in P. aeruginosa. These results provide a robust foundation for future structural optimization in antimicrobial research.
Isoprenoids, also known as terpenoids, are a diverse class of organic chemicals. This study evaluates them as potential antimicrobial scaffolds against Pseudomonas aeruginosa.
The study found that short-chain non-canonical C6-C7 isoprenoids displayed more consistent and discriminating antimetabolic profiles compared to longer chain variants.
The position of methyl groups determines the activity threshold and the dynamics of metabolic recovery in the pathogen, making positional isomerism a key factor.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Niçin RT et al. Structure-activity relationships of canonical and methyl-substituted isoprenoids delineate determinants of antimetabolic activity in Pseudomonas aeruginosa. Lett Appl Microbiol. 2026 Jun 11. doi: undefined. PMID: 42275104.
Cox SD, et al. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol. 2000;88(1):170-175.
Trombetta D, et al. Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother. 2005;49(6):2474-2478.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This research delineates how carbon chain length, methyl substitution, and oxygenation status influence the antimetabolic activity of isoprenoids against Pseudomonas aeruginosa, identifying specific C6-C7 scaffolds as promising candidates for future antimicrobial development.
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today